Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: A transiliac bone biopsy study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2562-2572

  Cohen, Adi ^a   Dempster, David W ^b   Recker, Robert R ^c   Lappe, Joan M ^c   Zhou, Hua ^b   Zwahlen, Alexander ^d   Müller, Ralph ^d   Zhao, Binsheng ^a   Guo, Xiaotao ^a   Lang, Thomas ^e   Saeed, Isra ^e   Liu, X Sherry ^a   Guo, X Edward ^a   Cremers, Serge ^a   Rosen, Clifford J ^f   Stein, Emily M ^a   Nickolas, Thomas L ^a   McMahon, Donald J ^a   Young, Polly ^a   Shane, Elizabeth ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b HELEN HAYES HOSPITAL   (United States)

^c CREIGHTON UNIVERSITY   (United States)

^d ETH ZURICH   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; CALCIUM; FOLLITROPIN; LEPTIN; OSTEOCALCIN; PARATHYROID HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C;

ABDOMINAL FAT; ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY MASS; BONE BIOPSY; BONE DENSITY; BONE REMODELING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; NORMAL HUMAN; OBESITY; OSSIFICATION; POROSITY; PREMENOPAUSE; PRIORITY JOURNAL; RIGIDITY; TISSUE LEVEL; TRABECULAR BONE; TRUNK;

ABDOMINAL FAT; ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; BIOPSY; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OSTEOGENESIS; PREMENOPAUSE; REGRESSION ANALYSIS;

EID: 84878495700     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1047     Document Type: Article

References (74)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307:491-497.
2. Nejat EJ, Polotsky AJ, Pal L. Predictors of chronic disease at midlife and beyond - the health risks of obesity. Maturitas. 65:106-111.
3. Klein KO, Larmore KA, de Lancey E, Brown JM, Considine RV, Hassink SG. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab. 1998;83:3469-3475. (Pubitemid 28500873)
4. Reid IR, Plank LD, Evans MC. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab. 1992;75:779-782.
5. Albala C, Yanez M, Devoto E, Sostin C, Zeballos L, Santos JL. Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes Relat Metab Disord. 1996;20:1027-1032. (Pubitemid 26366457)
6. Yamauchi M, Sugimoto T, Yamaguchi T, et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf). 2001;55:341-347. (Pubitemid 32823044)
7. De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330-1338. (Pubitemid 41532085)
8. Pittas A, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009;94:827-832.
9. Bredella MA, Torriani M, Ghomi RH, et al. Determinants of bone mineral density in obese premenopausal women. Bone. 2011;48:748-754.
10. Bredella MA, Torriani M, Ghomi RH, et al. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring). 2011;19:49-53.
11. Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab. 2009;94:3387-3393.
12. Pollock NK, Laing EM, Hamrick MW, Baile CA, Hall DB, Lewis RD. Bone and fat relationships in postadolescent black females: a pQCT study. Osteoporos Int. 2011;22:655-665.
13. Janicka A, Wren TA, Sanchez MM, et al. Fat mass is not beneficial to bone in adolescents and young adults. J Clin Endocrinol Metab. 2007;92:143-147. (Pubitemid 46075009)
14. Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab. 2007;92:1640-1646. (Pubitemid 46997165)
15. Sheu Y, Cauley JA. The role of bone marrow and visceral fat on bone metabolism. Curr Osteoporos Rep. 2011;9:67-75.
16. Russell M, Mendes N, Miller KK, et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010;95:1247-1255.
17. Choi HS, Kim KJ, Kim KM, et al. Relationship between visceral adiposity and bone mineral density in Korean adults. Calcif Tissue Int. 2010;87:218-225.
18. Nielson CM, Marshall LM, Adams AL, et al. BMI and fracture risk in older men: the osteoporotic fractures inmenstudy (MrOS). J Bone Miner Res. 2011;26:496-502.
19. Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr. 2006;83:146-154. (Pubitemid 44699248)
20. Compston JE, Watts NB, Chapurlat R, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med. 2011;124:1043-1050.
21. Skerry TM. The response of bone to mechanical loading and disuse: fundamental principles and influences on osteoblast/osteocyte homeostasis. Arch Biochem Biophys. 2008;473:117-123.
22. Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res. 2011;6:30.
23. Ibrahim SE, El Shishtawky HF, Helmy A, Galal ZA, Salam MHA. Serum leptin concentration, bone mineral density and bone biochemical markers in a sample of Egyptian women: a possible relationship. Egyptian Rheumatologist. 2011;33:171-177.
24. Cohen A, Recker RR, Lappe J, et al. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density. Osteoporos Int. 2012;23:171-182.
25. Albanes D, Conway JM, Taylor PR, Moe PW, Judd J. Validation and comparison of eight physical activity questionnaires. Epidemiology. 1990;1:65-71. (Pubitemid 20255625)
26. Pols MA, Peeters PH, Bueno-De-Mesquita HB, et al. Validity and repeatability of a modified Baecke questionnaire on physical activity. Int J Epidemiol. 1995;24:381-388.
27. Cohen A, Dempster D, Stein E, et al. Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab. 2012;97:2782-2791.
28. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem. 1982;16:801-810. (Pubitemid 13228095)
29. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-1495. (Pubitemid 38680001)
30. Liu XS, Cohen A, Shane E, et al. Bone density, geometry, microstructure, and stiffness: relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women. J Bone Miner Res. 2010;25:2229-2238.
31. Cohen A, Lang T, McMahon DJ, et al. Central QCT reveals cortical and trabecular structural defects in premenopausal women with idiopathic osteoporosis, regardless of fracture history. J Clin Endocrinol Metab. 2012;97(11):4244-4252.
32. Crawford RP, Cann CE, Keaveny TM. Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone. 2003;33:744-750. (Pubitemid 37222401)
33. Keyak JH, Kaneko TS, Tehranzadeh J, Skinner HB. Predicting proximal femoral strength using structural engineering models. Clin Orthop Relat Res. 2005;219-228. (Pubitemid 41099091)
34. Zhao B, Colville J, Kalaigian J, et al. Automated quantification of body fat distribution on volumetric computed tomography. J Comput Assist Tomogr. 2006;30:777-783. (Pubitemid 44368215)
35. Irlbeck T, Massaro JM, Bamberg F, O'Donnell CJ, Hoffmann U, Fox CS. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study. Int J Obes (Lond). 2010;34:781-787.
36. Dempster DW, Shane E. Bone quantification and dynamics of bone turnover. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. Philadelphia: J. B. Lippincott Co; 2002:475-479.
37. Ruegsegger P, Koller B, Muller R. A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int. 1996;58:24-29. (Pubitemid 26028374)
38. Cohen A, Dempster DW, Muller R, et al. Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int. 2010;21:263-273.
39. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res. 1999;14:1167-1174. (Pubitemid 29314060)
40. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
41. Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int. 2008;19:1323-1330.
42. Bredella MA, Ghomi RH, Thomas BJ, et al. Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring). 2010;18:2227-2233.
43. Snijder MB, Visser M, Dekker JM, et al. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord. 2002;26:984-993. (Pubitemid 34756183)
44. Ackerman KE, Davis B, Jacoby L, Misra M. DXA surrogates for visceral fat are inversely associated with bone density measures in adolescent athletes with menstrual dysfunction. J Pediatr Endocrinol Metab. 2011;24:497-504.
45. Yamaguchi T, Kanazawa I, Yamamoto M, et al. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone. 2009;45:174-179.
46. Adams J, Bishop N. DXA in adults and children. In: Rosen CJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington, DC: American Society for Bone and Mineral Research; 2008:152-158.
47. Hangartner TN, Johnston CC. Influence of fat on bone measurements with dual-energy absorptiometry. Bone Miner. 1990;9:71-81. (Pubitemid 20100902)
48. Bini V, Igli Baroncelli G, Papi F, Celi F, Saggese G, Falorni A. Relationships of serum leptin levels with biochemical markers of bone turnover and with growth factors in normal weight and overweight children. Horm Res. 2004;61:170-175. (Pubitemid 38437686)
49. Dimitri P, Wales JK, Bishop N. Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. Bone. 2011;48:189-196.
50. Grethen E, Hill KM, Jones R, et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab. 2012;97:1655-1662.
51. Lee SW, Jo HH, Kim MR, You YO, Kim JH. Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol Endocrinol. 2012;28:472-477.
52. Garcia-Martin A, Cortes-Berdonces M, Luque-Fernandez I, Rozas-Moreno P, Quesada-Charneco M, Munoz-Torres M. Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause. 2011;18:537-541.
53. Papakitsou EF, Margioris AN, Dretakis KE, et al. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas. 2004;47:185-193. (Pubitemid 38270396)
54. Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U, Mellstrom D. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009;24:785-791.
55. Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab. 2008;19:161-166. (Pubitemid 351847838)
56. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. PNAS. 2008;105:5266-5270. (Pubitemid 351738545)
57. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol. 2006;2:35-43. (Pubitemid 43153647)
58. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation. Endocrinology. 2002;143:2376-2384. (Pubitemid 34521584)
59. Grey A. Thiazolidinedione-induced skeletal fragility-mechanisms and implications. Diabetes Obes Metab. 2009;11:275-284.
60. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18:1319-1328. (Pubitemid 47389469)
61. Meunier P, Aaron J, Edouard C, Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res. 1971;80:147-154.
62. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology. 2001;2:165-171. (Pubitemid 32851325)
63. Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol. 2002;55:693-698. (Pubitemid 34970093)
64. Bredella MA, Fazeli PK, Miller KK, et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab. 2009;94:2129-2136.
65. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol. 2001;22:1620-1627. (Pubitemid 32862282)
66. Schellinger D, Lin CS, Lim J, Hatipoglu HG, Pezzullo JC, Singer AJ. Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: their ratio as a new indicator of bone weakening. AJR Am J Roentgenol. 2004;183:1761-1765. (Pubitemid 44210553)
67. Thomas JD, Monson JP. Adult GH deficiency throughout lifetime. Eur J Endocrinol. 2009;161(suppl 1):S97-S106.
68. Weaver JU, Monson JP, Noonan K, et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab. 1995;80:153-159.
69. Goodpaster BH, Krishnaswami S, Resnick H, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care. 2003;26:372-379. (Pubitemid 36929058)
70. Miyawaki T, Abe M, Yahata K, Kajiyama N, Katsuma H, Saito N. Contribution of visceral fat accumulation to the risk factors for atherosclerosis in non-obese Japanese. Intern Med. 2004;43:1138-1144. (Pubitemid 40074149)
71. Sironi AM, Gastaldelli A, Mari A, et al. Visceral fat in hypertension: influence on insulin resistance and β-cell function. Hypertension. 2004;44:127-133. (Pubitemid 39014227)
72. Fox CS, Massaro JM, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39-48. (Pubitemid 47016245)
73. Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab. 2010;95:5419-5426.
74. Khosla S, Riggs BL, Atkinson EJ, et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res. 2006;21:124-131. (Pubitemid 43023234)